Medical Equipment

Global Metered Dose Inhaler Devices Market Set To Expand To $21.05 Billion By 2030 At 5.3% CAGR

April 14, 2026April 14, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Projected Increase In Market Value Of The Metered Dose Inhaler Devices Market During 2026–2030?

The metered dose inhaler devices market size has experienced significant expansion in recent years. It is forecast to grow from $16.23 billion in 2025 to $17.12 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.5%. The growth observed in the past can be attributed to factors such as increasing asthma prevalence, a rise in COPD incidence, the widespread application of inhalation therapy, physician preference for MDIs, and the availability of generic inhalers.

The metered dose inhaler devices market is projected to experience substantial expansion over the upcoming years, reaching a valuation of $21.06 billion by 2030, driven by a compound annual growth rate (CAGR) of 5.3%. This anticipated growth during the forecast period can be ascribed to several factors, including the increasing adoption of smart inhalers, tighter environmental regulations concerning propellants, the expansion of homecare treatment options, the rising demand for digital adherence monitoring, and the emergence of new respiratory therapies. Key trends expected during this period encompass smart dose tracking inhalers, breath-actuated inhalation technology, the development of compact and portable device designs, improvements in dose accuracy, and the widespread adoption of eco-friendly propellants.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/metered-dose-inhaler-devices-global-market-report

What Key Drivers Are Fueling The Growth Of The Metered Dose Inhaler Devices Market?

The expanding occurrence of chronic obstructive pulmonary diseases is anticipated to boost the metered dose inhaler devices market’s expansion in the future. COPD, a progressive ailment of the lungs, involves obstructed airflow, frequently resulting from prolonged exposure to irritants like cigarette smoke, manifesting as difficulty breathing, coughing, and wheezing. This rising incidence of COPD stems from various factors, including tobacco consumption, environmental air contamination, an aging demographic, and delays in recognizing or treating the condition. MDI devices aid in the management of COPD by precisely delivering medication into the lungs, thereby offering quick alleviation and enhancing respiratory flow. For example, data from December 2023 by the National Institutes of Health, a US-based government agency, forecasts a surge in COPD cases from 532 million in 2030 to 592 million by 2050. Consequently, the growing prevalence of chronic obstructive pulmonary diseases is fueling the expansion of the metered dose inhaler devices market.

Which Segment Classifications Are Used In The Metered Dose Inhaler Devices Market Segment Analysis?

The metered dose inhaler devices market covered in this report is segmented –

1) By Type: Desktop Metered Dose Inhaler Devices, Portable Metered Dose Inhaler Devices, Other Types

2) By Distribution Channel: Online, Offline

3) By Application: Asthma, Chronic Obstructive Pulmonary Disease, Other Applications

4) By End-User: Hospitals, Clinics, Homecare Settings, Other End Users

Subsegments:

1) By Desktop Metered Dose Inhaler Devices: Standard desktop MDI devices, High-performance desktop MDI devices, Smart desktop MDI devices

2) By Portable Metered Dose Inhaler Devices: Conventional portable MDI devices, Advanced portable MDI devices, Smart portable MDI devices

3) By Other Types: Nebulizer-Based MDI devices, Dry powder inhaler (DPI) combined devices, Soft mist inhaler (SMI) devices, Other specialized MDI devices

What Trends Are Influencing The Metered Dose Inhaler Devices Market?

Leading companies within the metered dose inhaler devices market are concentrating on creating technologically advanced solutions, such as pressurized metered dose inhalers, to boost drug delivery effectiveness and elevate patient compliance. Pressurized metered-dose inhalers (pMDIs) are inhalation devices that deliver a precise amount of medication in aerosol form using a pressurized propellant. For example, in July 2023, Lupin Limited, an India-based pharmaceutical company, introduced Luforbec 100/6, a pressurized metered dose inhaler (pMDI), for treating adult asthma and chronic obstructive pulmonary disease (COPD) in Germany. This product combines beclometasone (100 µg) and formoterol (6 µg), offering an effective solution for patients requiring combination therapy. Notably, Luforbec is priced approximately 47% lower than the fixed reference price, significantly enhancing its accessibility. With asthma impacting about 5% of adults in Germany, this launch underscores Lupin’s commitment to addressing critical healthcare needs and improving patient outcomes in respiratory care.

Which Firms Are Contributing To The Metered Dose Inhaler Devices Market Ecosystem?

Major companies operating in the metered dose inhaler devices market are Pfizer Inc., Merck & Co. Inc., AstraZeneca PLC, GlaxoSmithKline plc, 3M Company, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Berry Global Inc., AptarGroup Inc., Philips Healthcare, Chiesi Farmaceutici S.p.A., Cipla Limited, Gerresheimer AG, Zydus Lifesciences Limited, Mylan N.V., Nemera, Beximco Pharmaceuticals Limited, Cohero Health Inc., Bespak Europe Ltd., Trudell Medical International, Iconovo AB

Get The Full Metered Dose Inhaler Devices Market Report:

https://www.thebusinessresearchcompany.com/report/metered-dose-inhaler-devices-global-market-report

Which Region Represents The Largest Share Of The Metered Dose Inhaler Devices Market?

North America was the largest region in the metered dose inhaler devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the metered dose inhaler devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Metered Dose Inhaler Devices Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/metered-dose-inhaler-devices-global-market-report

Browse Through More Reports Similar to the Global Metered Dose Inhaler Devices Market 2026, By The Business Research Company

Respiratory Inhaler Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/respiratory-inhaler-devices-global-market-report

Smart Inhalers Market Report 2026

https://www.thebusinessresearchcompany.com/report/smart-inhalers-global-market-report

Albuterol Market Report 2026

https://www.thebusinessresearchcompany.com/report/albuterol-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795